By Adam Pick on June 19, 2014
In case you missed the big news last week…
By Adam Pick on March 3, 2014
The world’s very first heart surgery was said to have taken place only a little more than a century ago. Today, it’s almost common place, with millions undergoing surgeries like cardiac catheterizations, coronary artery bypass grafts and valve related procedures.
Technology Update: The Two-Part Vitality Heart Valve Replacement Explained by Ivan Vesely, Founder of ValveXchange
By Adam Pick on October 15, 2013
New heart valve companies don’t pop up often. The last time there was an innovation rush in this field was about 10 years ago, when several transcatheter heart valve companies were launched to develop valves delivered to the patient’s heart via catheter. Since that time, the Edwards SAPIEN class of products got FDA approval in the United States, and a whole bunch more are being sold in Europe.
By Adam Pick on February 18, 2013
By Adam Pick on October 19, 2012
Patient interest specific to transcatheter aortic valve implantation is very, very, very high. However, patients with mitral valve disorders, including mitral regurgitation, are wondering, “What about me? Are there any catheter-based solutions for mitral valve surgery?”
By Adam Pick on June 16, 2012
The possibility of aortic valve replacement without an incision to the sternum or ribs of the patient has become a reality for select patient categories. Together, our community has followed the evolution of catheter-based technologies including the SAPIEN heart valve replacement by Edwards Lifesciences which received FDA approval for “inoperable” patients last year. Needless to say, patient interest specific to this and other transcatheter devices, including the CoreValve and the MitraClip, is significant.
By Adam Pick on March 26, 2012
For those of you monitoring the progress of the transformational Edwards SAPIEN Valve, which replaces the aortic valve in “non-operable” patients, more encouraging data was just released at the American College of Cardiology Conference in Chicago. The SAPIEN is the first catheter-based device, approved by the FDA, that replaces a valve suffering from aortic valve stenosis without any trauma to the patient’s sternum or ribs.
Technology Update: “Will Extracellular Matrix Help Patients Grow Their Own Heart Valves?” By Dr. Marc Gerdisch
By Adam Pick on February 15, 2011
Advances in medical technology for valvular treatment continue to evolve rapidly. Recently, I learned more about the use of Extracelluar Matrix (ECM) for heart valve repair and remodeling from Dr. Marc Gerdisch, the chief of cardiothoracic surgery at St. Francis Heart Center in Indianapolis, Indiana. In 2008, Doctor Gerdisch was the world’s first surgeon to use ECM to repair a damaged heart valve.
Technology Update: Cardiologists & Surgeons Evaluate The SAPIEN Heart Valve Replacement Trial (Part II)
By Adam Pick on October 15, 2010
When the latest results of the PARTNER trial became available, many in the medical, investment and patient communities quickly analyzed the data specific to the new SAPIEN heart valve replacement. As you may be aware, the SAPIEN (i) requires no trauma to the sternum during aortic valve replacement, (ii) is currently used for high-risk patients suffering from aortic stenosis, and (iii) has yet to receive FDA approval in the United States.
By Adam Pick on September 1, 2009
I’m fascinated by the different tools and technologies that help surgeons reconstruct the human heart.